Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
As of December 2024 Novo Nordisk has a market cap of ₹33.787 Trillion. This makes Novo Nordisk the world's 22th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 21st, 2024 the market cap of Novo Nordisk was reported to be: